Zobrazeno 1 - 10
of 5 020
pro vyhledávání: '"experimental therapeutics"'
Publikováno v:
TIME Magazine. 5/28/2001, Vol. 157 Issue 21, p62. 8p. 5 Color Photographs, 2 Diagrams.
Autor:
Mackenzie Fijardo, Jennifer Yin Yee Kwan, Pierre-Antoine Bissey, Deborah E. Citrin, Kenneth W. Yip, Fei-Fei Liu
Publikováno v:
EBioMedicine, Vol 103, Iss , Pp 105089- (2024)
Summary: Advances in radiation techniques have enabled the precise delivery of higher doses of radiotherapy to tumours, while sparing surrounding healthy tissues. Consequently, the incidence of radiation toxicities has declined, and will likely conti
Externí odkaz:
https://doaj.org/article/3dbfe9c3fac44a0e8a83ccad3529c73d
Autor:
Ajami Gikandi, Susan N. Chi, Kee Kiat Yeo, Allison F. O'Neill, David S. Shulman, Steven G. DuBois, Natalie B. Collins
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Immune checkpoint inhibitors (ICI) have improved outcomes in a variety of adult cancers and are prescribed with increasing frequency across oncology. However, patterns of off‐label use of ICI in pediatrics remain unclear. Method
Externí odkaz:
https://doaj.org/article/c0b09fda39d84998acabc99d862c2cad
Autor:
Alberto Hernando‐Calvo, Eoghan Malone, Daphne Day, Amy Prawira, Ilan Weinreb, S. Y. Cindy Yang, Horace Wong, Angela Rodriguez, Sarah Jennings, Anneli Eliason, Lisa Wang, Anna Spreafico, Lillian L. Siu, Aaron R. Hansen
Publikováno v:
Cancer Medicine, Vol 12, Iss 20, Pp 20299-20310 (2023)
Abstract Objectives We aimed to evaluate the activity of selinexor, an oral selective inhibitor of nuclear export, in patients with recurrent or metastatic salivary gland tumors (SGT). Methods GEMS‐001 is an open‐label Phase 2 study for patients
Externí odkaz:
https://doaj.org/article/efef56b21f914e1590723168e744ce08
Autor:
Jacob J. Adashek, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Pradip De, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Jeffrey M. Conroy, Paul DePietro, Scott Lippman, Razelle Kurzrock
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13155-13166 (2023)
Abstract Background Lymphocyte activation gene 3 (LAG‐3) or CD223 is a transmembrane protein that serves as an immune checkpoint which attenuates T‐cell activation. Many clinical trials of LAG‐3 inhibitors have had modest effects, but recent da
Externí odkaz:
https://doaj.org/article/cfe72fc33e194e9395740e5950d4b95c
Autor:
Parker Parrella, Annabelle B. Elikan, Helen V. Kogan, Fatoumata Wague, Corey A. Marshalleck, Jonathan W. Snow
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTMicrosporidia cause disease in many beneficial insects, including honey bees, yet few pathogen control tools are available for protecting these important organisms against infection. Some evidence suggests that microsporidia possess a reduced
Externí odkaz:
https://doaj.org/article/f5bb6efec8fb4398ac83ef9d6e886fad
Autor:
Jung, Sin-ho1 (AUTHOR) jung0005@mc.duke.edu, Kang, SunJ.2 (AUTHOR), McCall, LindaM.3 (AUTHOR), Blumenstein, Brent4 (AUTHOR)
Publikováno v:
Journal of Biopharmaceutical Statistics. Dec2005, Vol. 15 Issue 6, p969-979. 11p. 1 Chart.
Autor:
RUSTHOVEN, JAMES J.1
Publikováno v:
Ethics & Medicine: An International Journal of Bioethics. Spring2014, Vol. 30 Issue 1, p17-33. 17p.
Autor:
Desestret, Virginie1,2,3,4, Riou, Adrien1, Chauveau, Fabien1, Cho, Tae-Hee1,2,3, Devillard, Emilie4, Marinescu, Marilena1, Ferrera, René3,5, Rey, Catherine6, Chanal, Marie4, Angoulvant, Denis2,3,5, Honnorat, Jérôme2,3,4, Nighoghossian, Norbert1,2,3, Berthezène, Yves1,2,3, Nataf, Serge2,3,4, Wiart, Marlène1 marlene.wiart@creatis.insa-lyon.fr
Publikováno v:
PLoS ONE. Jun2013, Vol. 8 Issue 6, p1-12. 12p.
Autor:
Sobel, Michael E.1, Muthén, Bengt2
Publikováno v:
Biometrics. Dec2012, Vol. 68 Issue 4, p1037-1045. 9p. 3 Charts.